KATIE ZAJECHOWSKI: Open Payments
NPI 1043595713 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 8 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $167 · 2025 $502
Food & beverage: $403Education: $100
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 1 | $195 |
| SOBI, INC | 1 | $100 |
| Galvanize Therapeutics, Inc | 1 | $95 |
| Incyte Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Genmab U.S., Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $17 |
Products named: MONOFERRIC, ALIYA SYSTEM, MONJUVI, VERZENIO, Epkinly, ULTOMIRIS, BOSULIF.
Industry payments across FL — which companies pay providers there.
